Chemed Corp (CHE) Social Stream
CHEMED CORP (CHE) Price Targets From Analysts
Use the tables below to see what analysts covering CHEMED CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-07 | 3 | $609 | $580 | $596.333 | $514.46 | 15.91% |
| 2022-01-19 | 3 | $610 | $580 | $599.666 | $514.46 | 16.56% |
| 2022-05-10 | 3 | $609 | $575 | $588 | $514.46 | 14.29% |
| 2022-07-28 | 2 | $580 | $575 | $577.5 | $514.46 | 12.25% |
| 2022-11-01 | 3 | $580 | $541 | $565.333 | $514.46 | 9.89% |
| 2023-02-08 | 3 | $580 | $545 | $566.666 | $514.46 | 10.15% |
| 2023-02-24 | 3 | $590 | $545 | $571.666 | $514.46 | 11.12% |
| 2023-03-14 | 3 | $590 | $580 | $585.666 | $514.46 | 13.84% |
| 2023-04-27 | 3 | $610 | $580 | $592.333 | $514.46 | 15.14% |
| 2023-04-28 | 3 | $610 | $587 | $602.333 | $514.46 | 17.08% |
| 2023-06-06 | 3 | $610 | $610 | $610 | $514.46 | 18.57% |
| 2023-07-27 | 3 | $610 | $590 | $603.333 | $514.46 | 17.28% |
| 2023-07-31 | 3 | $610 | $576 | $592 | $514.46 | 15.07% |
The Trend in the Analyst Price Target
Over the past 39 months, CHE's average price target has gone up $48.67.
CHE reports an average of 12.8% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-16 | 3 | 580 | 545 | 566.666 | 497.96 | 13.8% |
| 2023-02-08 | 3 | 580 | 545 | 566.666 | 496.93 | 14.03% |
| 2023-02-24 | 3 | 590 | 545 | 571.666 | 529.97 | 7.87% |
| 2023-04-27 | 3 | 610 | 580 | 592.333 | 544.42 | 8.8% |
| 2023-05-01 | 3 | 610 | 610 | 610.000 | 552.96 | 10.32% |
CHE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 2 | 1 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
CHE's average broker recommendation rating worsened by 0.33 over the prior 42 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, CHEMED CORP's average analyst price target is greater than 1383.57% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, CHEMED CORP's variance in analysts' estimates is lower than 51.31% of them.
- CHE has a greater number of analysts covering the stock than 83.01% of Healthcare stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, CHEMED CORP's upside potential (average analyst target price relative to current price) is greater than 231.12% of them.
Stocks similar to CHEMED CORP in the Healthcare industry regarding analyst recommendations and price targets are SEM, MD, and CMAX.
View All Top Stocks by Price Target
Is CHE a Buy, Hold or Sell? See the POWR Ratings now!